文献速递骨肌MR

分子病理在软组织肿瘤诊断中的作用:放射科医生需要了解的内容

The role of molecular pathology in soft tissue tumor diagnosis: what the radiologist needs to know.
PubMed 文献 · Skeletal Radiol · 2025-04-29

文章指出分子病理对软组织肉瘤影像诊断日益重要,分子检测聚焦细胞核遗传物质,识别突变、缺失和扩增等异常,2020年WHO软组织与骨肿瘤分类即以此为基础。文中通过MRI对照展示分子诊断对特定软组织肿瘤最终分类和诊断关键的病例,并给出教学要点。

要点

  • 分子病理已成为软组织肿瘤分类和诊断的关键依据,放射科医生需了解其基本概念。
  • 2020年WHO软组织与骨肿瘤分类建立在分子病理研究进展基础之上。
  • 文章以MRI对照病例展示分子诊断对特定软组织肿瘤最终分类和诊断的关键作用。

核心结论

  • 分子病理的快速发展增进了对肉瘤发病机制、诊断和分类的理解,并构成2020年WHO软组织与骨肿瘤分类的基础。

研究设计与样本

  • 本文为综述性教学文章,通过病例展示分子诊断对特定软组织肿瘤最终分类和诊断的关键作用,并附MRI对照与教学要点;原文未报告样本量与中心数。

临床应用与阅片要点

  • 文章以MRI对照病例展示分子诊断对特定软组织肿瘤最终分类和诊断关键的情形,并给出教学要点。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

For both general radiologists and those specializing in soft tissue sarcoma imaging, understanding the importance and basic concepts of molecular pathology is becoming increasingly relevant to current clinical practice. As molecular research identifies the most fundamental causes and markers of disease, diagnostic testing is increasingly focused on the cell nucleus and its genetic material. Identifying molecular abnormalities, such as mutations, deletions, and amplifications, has advanced our ability to diagnose genetic diseases, including a variety of cancers. Over the past two decades, molecular pathology has rapidly evolved, enhancing our understanding of sarcoma pathogenesis, diagnosis, and classification. This progress forms the foundation of the 2020 WHO classification of soft tissue and bone tumors. This article will highlight cases where molecular diagnostics are crucial for the definitive classification and diagnosis of select soft tissue tumors, with MRI correlation and key teaching points.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Parasu N, Mathew D, Aboelmagd S, et al. The role of molecular pathology in soft tissue tumor diagnosis: what the radiologist needs to know. Skeletal Radiol. 2025. PMID: 40301146. doi:10.1007/s00256-025-04934-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。